WILLOW Trademark

Trademark Overview


On Thursday, July 18, 2024, a trademark application was filed for WILLOW with the United States Patent and Trademark Office. The USPTO has given the WILLOW trademark a serial number of 98655178. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, September 3, 2024. This trademark is owned by Willow Laboratories, Inc.. The WILLOW trademark is filed in the Medical Instrument Products category with the following description:

Medical devices; Medical apparatus and instruments

General Information


Serial Number98655178
Word MarkWILLOW
Filing DateThursday, July 18, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical devices; Medical apparatus and instruments

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, July 18, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWillow Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events


Event DateEvent Description
Thursday, July 18, 2024NEW APPLICATION ENTERED
Thursday, July 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 20, 2024ASSIGNED TO EXAMINER
Tuesday, September 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 3, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 27, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, November 27, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, September 3, 2024NON-FINAL ACTION E-MAILED